Pharmaceutical Companies

Although the pharmaceutical industry spends approximately $20B a year to market its products to healthcare professionals and consumers, over $30B in sales are lost each year because of patient non-adherence. In both chronic and specialty categories, failure to maintain high levels of adherence results in significant loss of its patient base to the drug manufacturer. The benefits of improving adherence as a strategy toward retaining patients are obvious and significant.

Adopting strategies that employ patient-centric marketing efforts to retain existing customers can prove a huge win to every drug manufacturer. Aprexis adherence services can help manufacturers retain existing patients by ensuring that patients stay on track with appropriate medication taking, whether the regimen is short term or for a life-time condition such as hypertension, hyperlipidemia, diabetes, rheumatoid arthritis, multiple sclerosis, and any of the many other serious conditions that challenge patients. Services can include call-center contacts, automated reminders, and access to web-based medication information and patient education.